Real-world treatment patterns and characteristics among patients with agitation and dementia in the United States: findings from a large, observational, retrospective chart review

Manuscript Number: 

20-0127R2

Author(s): 
Ross A. Baker, Martin Cloutier, Ruth A. Duffy, Howard Fillit, Marjolaine Gauthier-Loiselle, Michael Grundman, Annie Guerin, Keva Gwin, Ann Hartry, Martin Ladouceur, Myrlene Sanon Aigbogun

Disclosures

Ross A. Baker

  • Sponsors:
    Full time employee of Otsuka

Martin Cloutier

  • Consulting Fees:
    I am an empoyee of Analysis Group, Inc., which has received consultancy fees from Otsuka Pharmaceutical Development & Commercialization, Inc.for the conduct of this study.

Ruth A. Duffy

  • Sponsors:
    Full time employee of Otsuka Pharmaceutical Development and Commercialization

Howard Fillit

  • Consulting Fees:
    Current consulting for which i receive fees ; Alector, vTv, Lundbeck/Otsuka, Biogen (RTI), Samus

Marjolaine Gauthier-Loiselle

  • Consulting Fees:
    I am an empoyee of Analysis Group, Inc., which has received consultancy fees from Otsuka Pharmaceutical Development & Commercialization, Inc.for the conduct of this study.

Michael Grundman

  • Consulting Fees:
    MG served as a paid clinical consultant to Otsuka

Annie Guerin

  • Consulting Fees:
    I am an empoyee of Analysis Group, Inc., which has received consultancy fees from Otsuka Pharmaceutical Development & Commercialization, Inc.for the conduct of this study.

Keva Gwin

  • Sponsors:
    Previously employed by Lundbeck

Ann Hartry

  • Sponsors:
    Full time employee of Lundbeck, LLC

Martin Ladouceur

  • Consulting Fees:
    At the time the study was conducted, I was an employee of Analysis Group, which has received consulting fees for this study.

Myrlene Sanon Aigbogun

  • Sponsors:
    Otsuka Pharmaceutical Inc